SCIRENA @ JPM WEEK“Select biotech & healthtech conversations.
Deal-by-deal.
Private by design.”
Leadership- Ashley MarinScirena structures selective biotech and healthtech investments through single-deal SPVs, translating complex science into clear, investable opportunities for non-technical capital.
In innovation, progress begins with signal—not noise.

